Meilleur Technologies Inc Announces Use of the NextGeneration Amyloid PET Imaging Biomarker NAV4694 in the Alzheimers Disease Neuroimaging Initiative 4 ADNI4

KNOXVILLE, Tenn. — Meilleur Technologies, Inc. today announced a research collaboration agreement with the Alzheimer’s Disease Neuroimaging Initiative 4, ADNI4, on the use of Meilleur’s [F-18]NAV-4694, an investigational imaging agent, in Positron Emission Tomography (PET) scans to assess the status amyloid plaque in the brain. Amyloid plaques are a hallmark…Read More